Skip to content
Le Rouge Medical
02 — Clinical Evidence

Clinical Evidence

Review clinical data and peer-reviewed studies supporting the effectiveness of our wound care products.

Eleven VACUTEX™ documents are published below — case reports, a multicentre randomized trial, and a review of an independent audit. Every file previews in the browser and downloads in one click. No registration, no forms.

01 — Featured Study

Case Series — Amsterdam UMC

VACUTEX may be effective in wound healing through rapid capillary action: a case study

Marjolein Lust MSc — Nurse Specialist, Cardiothoracic Surgery, Amsterdam UMC

7

PATIENTS — CASE SERIES, JAN–OCT 2024

AMSTERDAM UMC CASE STUDY

45

AVG DAYS TO WOUND HEALING

≈€10

PER DRESSING CHANGE, AS REPORTED — VS ≈€100 PER VAC CHANGE

Between January and October 2024, seven patients with wound problems after open heart surgery were treated with the VACUTEX™ rapid capillary action dressing at Amsterdam UMC. In all seven, VAC therapy had been terminated prematurely. Patients reported irritation from pump sounds (86%), painful dressing changes (86%), limited mobility (71%), and skin irritation (43%).

Treatment continued with the rapid capillary action dressing, changed twice a week, until each wound closed — no signs of infection, no exudate present. The average time to wound healing was 45 days.

The author also reports cost. A VAC change runs around €100; a change of the rapid capillary action dressing, around €10. Patients found the dressing pleasant: mobility improved, there were no pumping noises, and removal and application were perceived as less stressful than VAC therapy.

The study's conclusion keeps its own careful language — VACUTEX may be effective in wound healing through rapid capillary action. It is not identical to Negative Pressure Wound Therapy but has an autologous mechanism like NPWT.

“All wounds were healed after treatment.”
Reported result — Amsterdam UMC case series
  • 6 STERNAL WOUNDS · 1 LEG WOUND
  • VAC THERAPY AT 125mmHg — AVG 21 DAYS
  • RAPID CAPILLARY ACTION (VACUTEX™) — MEAN 24 DAYS

VACUTEX may be effective in wound healing through rapid capillary action: a case study

Download
Download PDF
02 — Document Register

VACUTEX™ Document Register

Eleven documents. One click each. No forms.

Case reports, a multicentre randomized trial, an independent audit review, and practical guidance for clinical use. Preview any document in the browser, or download what your evaluation requires.

  1. VACUTEX may be effective in wound healing through rapid capillary action: a case study — full study (PDF)

    Download
  2. VACUTEX may be effective in wound healing through rapid capillary action: a case study

  3. A Practical Alternative to NPWT in Rural Limb Preservation: A Case Report

    Download
  4. Capillary pressure in wound dressings

    Download
  5. Vacutex tips & tricks

    Download
  6. Review of an independent audit into the clinical efficacy of VACUTEX™

    Download
  7. VACUTEX™ capillary action dressing: a multicentre, randomized trial

    Download
  8. Novel treatments for targeting Oedema in Diabetic Foot Ulcers

    Download
  9. Vacutex – an effektive debridement procedure for the treatment of decubitus

    Download
  10. Promising results wound care new rapid capillary action dressing case series study

    Download
  11. Vacutex Case Study Alexandra Helena Jacoba Janssen

    Download
03 — CleanWND® Results

CleanWND® Debridement Results

Projected U.S. Launch 2026

CleanWND® is a non-woven, impregnated cloth that acts as an innovative debridement and therapy system for complex wounds. It removes debris and exudate thoroughly and practically painlessly from the wound and eliminates flakes and keratosis from the surrounding skin. The figures below are the manufacturer's clinical documentation.

The following figures contain real clinical wound photography.

CleanWND® debridement documentation, before and after. Manufacturer slide 1 of 3.
FIG. 01CleanWND® debridement documentation, before and after. Manufacturer slide 1 of 3.
CleanWND® clinical evidence series. Manufacturer slide 2 of 3.
FIG. 02CleanWND® clinical evidence series. Manufacturer slide 2 of 3.
CleanWND® clinical evidence series. Manufacturer slide 3 of 3.
FIG. 03CleanWND® clinical evidence series. Manufacturer slide 3 of 3.
04 — Clinical Support

Request an in-service or speak with our clinical nurse specialist

We provide dedicated Clinical Nurse Support: consultations and product in-services led by our wound care clinical nurse specialist. Bring your questions about the evidence — we will walk through it with your team.

Interested in becoming a distributor?

We are open to additional distribution partners in the U.S. and Caribbean — and to adding products direct from manufacturers.

Our team responds within one business day — typically sooner.